Research
Does switching from oral extended-release methylphenidate to the methylphenidate transdermal system affect health-related quality-of-life and medication satisfaction for children with attention-deficit/hyperactivity disorder?
-
* Corresponding author: Oscar G Bukstein buksteinog@upmc.edu
Child and Adolescent Psychiatry and Mental Health 2009, 3:39 doi:10.1186/1753-2000-3-39
No comments have yet been made on this article.